Locally Advanced Pancreatic Cancer clinical trials

Explore recruiting locally advanced pancreatic cancer clinical trials.

Recruiting locally advanced pancreatic cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Locally Advanced Pancreatic Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Prospective, Randomized, Controlled, Multinational, Phase 2/3, Open-Label Trial to Evaluate the Efficacy and Safety of SIL204-SL Administered as an Integrated Therapeutic Regimen in Combination with Chemotherapy vs. Chemotherapy Treatment Alone in Participants with Locally Advanced Pancreatic Cancer

Germany

Phase II and Phase III (Integrated) EU CTIS Study details

A Single-center, Prospective, Non-randomized, Open, Pilot Study Evaluating the Safety and Performance of the Extroducer® Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients with Unresectable Locally Advanced Pancreatic Cancer

Sweden

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 2, Randomized, Open-Label, Controlled Study to Evaluate the Efficacy and Safety of Ampligen® Compared to Control Group / No Treatment Following FOLFIRINOX in Subjects with Locally Advanced Pancreatic Adenocarcinoma

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Prospective phase IIb study to evaluate the efficacy of laparoscopic electrochemotherapy in the treatment of locally advanced pancreatic cancer - ECT-LAPC Laparoscopic

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

PHASE II study evaluating the benefit of Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Standard versus Prolonged Neoadjuvant (Conversion) Chemotherapy to prolong survival of patients with Borderline and Locally Advanced Pancreatic Cancer: a phase III randomized controlled trial

Sweden, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Locally Advanced Pancreatic Cancer trials by city

Locally Advanced Pancreatic Cancer in Toronto Locally Advanced Pancreatic Cancer in Vancouver Locally Advanced Pancreatic Cancer in Montreal Locally Advanced Pancreatic Cancer in Calgary Locally Advanced Pancreatic Cancer in Edmonton Locally Advanced Pancreatic Cancer in Ottawa Locally Advanced Pancreatic Cancer in Winnipeg Locally Advanced Pancreatic Cancer in Quebec City Locally Advanced Pancreatic Cancer in Hamilton Locally Advanced Pancreatic Cancer in Kitchener Locally Advanced Pancreatic Cancer in London Locally Advanced Pancreatic Cancer in Halifax Locally Advanced Pancreatic Cancer in New York Locally Advanced Pancreatic Cancer in Los Angeles Locally Advanced Pancreatic Cancer in Chicago Locally Advanced Pancreatic Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease